Navigation Links
PRA Hosts Biotech 2009 - Challenges and Opportunities in R&D
Date:4/16/2009

Interactive workshops to exchange ideas with experts on clinical development: Copenhagen and Munich

RALEIGH, N.C., April 16 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, will host two interactive workshops on how to manage the challenges posed by current market conditions, improve planning for successful trials and marketing approvals, and increase efficiency working with different vendors throughout the development process. The first workshop will take place in Munich on April 21, 2009; the second workshop will occur on April 23, 2009 in Copenhagen.

Guest speakers from the biotech sector, special vendors, and analysts will present and discuss the challenges faced by the biotechnology industry in the current environment. Speakers for the event in Munich include: Dr. Michael Kirchengast - VP and Head, Scientific Affairs at PRA; Dr. Ute Berger - VP, Medical Affairs at PRA; Dr. Siegfried Bialojan - Executive Director and Head European Life Science Center at Ernst & Young; Dr. Graham Bunn - VP Global Partnerships & Alliances at Medidata Solutions Worldwide; and Dr. Frank Henke - Head Clinical Operations at BioTie. Speakers for Copenhagen include: Mr. John Richmond - Project Manager, Europe for invivodata, inc.; as well as speakers from the Munich event: Dr. Bialojan from Ernst & Young, and Dr. Berger and Dr. Kirchengast from PRA.

These workshops will be of special interest to professionals in the Biotech Industry. Space is limited. If you wish to participate, please send your contact details to PRAeventsEU@praintl.com.

PRA's clinical development services are well suited for the needs of emerging biotechs because we combine a totally flexible service offering which ranges from single services to complete development programs with our globally integrated solutions. Over 50% of PRA's project work is with biotechnology companies - a direct result of our flexible operational model and commitment to excellence.

About PRA International

PRA International is one of the leading global clinical research organizations, conducting clinical trials in more than 65 countries across six continents. PRA provides outsourced clinical services across all phases of pharmaceutical and biotech drug development. Although we specialize in Oncology, CNS, Respiratory/Allergy, Cardiovascular and Infectious Diseases, we perform studies in all therapeutic areas. PRA has supported over 2,100 clinical trials through its 35 global offices. PRA's therapeutic expertise, global reach and project experience, combined with extensive local knowledge, enable our project teams to deliver consistent and on time performance for our clients.

To learn more about PRA International, please visit http://www.prainternational.com, email endpoints@praintl.com or call our Global Headquarters at +1 (919) 786-8200.


'/>"/>
SOURCE PRA International
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. HMS Holdings Corp. Hosts First Quarter 2009 Financial Teleconference and Presentation
2. April is National Autism Awareness Month: LoJack Hosts Educational Podcast Featuring Panel of Experts Addressing Autism Issues
3. Good Samaritan Hospital-Dayton Hosts Local Students to Explore Health Careers, Learn Human Anatomy
4. Courage Center Hosts College Scholarship Signing Ceremony Thursday, April 9, 2009
5. Camp Courage Hosts Open House Sunday, April 26
6. Cochlear Americas Hosts Celebration 2009 for Cochlear Implant Recipients and Their Families
7. Subtle Fillers Bring Breathtaking Results; The Neigel Center for Cosmetic and Laser Surgery Hosts Its March 27th Filler Day Specials!
8. Abbott Hosts Conference Call for First-Quarter Earnings
9. Spring Forward with a New You! The Neigel Center for Cosmetic and Laser Surgery Hosts Its May 3rd Pre-Mothers Day Open House!
10. Ribbit Marketing Hosts Contest for NC Film Students
11. NSC Hosts National Poison Prevention Week News Conference, Tuesday, March 17
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her ... would lash out at his family verbally and physically. , “When something upset him, he ... he would use it. He would throw rocks at my other children and say he ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas ... , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct ...
(Date:6/24/2016)... ... 2016 , ... People across the U.S. are sharpening their pencils and honing ... contest in which patients and their families pay tribute to a genetic counselor by ... Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In ...
(Date:6/24/2016)... Nevada (PRWEB) , ... June 24, 2016 , ... ... Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing operations ... in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a ...
(Date:6/24/2016)... ... 24, 2016 , ... Venture Construction Group (VCG) sponsors Luke’s Wings ... 20th at the Woodmont Country Club at 1201 Rockville Pike, Rockville, Maryland, 20852. ... service members that have been wounded in battle and their families. Venture Construction Group ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 ... appointment of Dr. Edward Futcher to ... Director, effective June 23, 2016.Dr. Futcher was also ... and Governance Committees.  As a non-executive member of ... expertise and strategic counsel to VolitionRx in connection ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... 52" report to their offering. ... creates a favourable commercial environment for MedImmune to enter. The ... that will serve to drive considerable growth for effective anti-influenza ... to cap sales considerably, but development is still in its ...
Breaking Medicine Technology: